Finance

Lists
Why is PDSB down 10.96%?
Dive Deeper
PDSB:NASDAQ
PDS Biotechnology Corp
$0.87
-10.96%
(-0.11) 1D
$0.87
-0.30% (-0.0026)
After hours
Closed: Nov 13, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PDSB...
Open
$0.99
High
$0.99
Low
$0.75
Mkt. cap
63.24M
Avg. vol.
9.89M
Volume
5.92M
52-wk high
$1.79
52-wk low
$0.20
EPS
-$0.65
Beta
1.16
Shares outstanding
105.00M
No. of employees
21
Open
$0.99
High
$0.99
Low
$0.75
Mkt. cap
63.24M
Avg. vol.
9.89M
Volume
5.92M
52-wk high
$1.79
52-wk low
$0.20
EPS
-$0.65
Beta
1.16
Shares outstanding
105.00M
No. of employees
21
News stories
From web sources and news partners
About PDS Biotechnology Corp
CEO-
Employees21
Founded2005
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitepdsbiotech.com
Analyst ratings
Based on 2 analysts giving stock ratings to PDSB in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for PDSB in the last 3 months.
Highest
Current $0.87
$5.00 (+473.00%)
Average
$4.50 (+415.70%)
Lowest
$4.00 (+358.40%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
$5.00
+473%
11/13/2026
Mayank Mamtani
B. Riley Securities
Buy
Maintained
$4.00
+358.4%
10/29/2026
Unknown Analyst
B. Riley Securities
Buy
Maintained
$4.00
+358.4%
10/29/2026
James Molloy
Alliance Global Partners
Buy
Reiterated
$4.50
+415.7%
04/02/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4.58M
4.41M
3.46M
3.27M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.56M
2.27M
3.06M
3.23M
Operating expense
8.14M
6.67M
6.52M
6.50M
Total operating expenses
8.14M
6.67M
6.52M
6.50M
Operating income
-8.14M
-6.67M
-6.52M
-6.50M
Other non operating income
-
-
-
-
EBT including unusual items
-9.01M
-7.56M
-7.35M
-9.75M
EBT excluding unusual items
-9.01M
-7.56M
-7.35M
-9.75M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-9.01M
-7.56M
-7.35M
-9.75M
Net profit margin
-
-
-
-
Earnings per share
-0.19
-0.14
-0.13
-0.18
Interest and investment income
281.11K
224.66K
186.81K
125.40K
Interest expense
-1.15M
-1.11M
-1.01M
-3.38M
Net interest expenses
-869.27K
-888.21K
-827.97K
-3.25M
Depreciation and amortization charges
-
-
-
-
EBITDA
-8.13M
-6.66M
-6.51M
-6.48M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps